Heterogeneous in vivo behavior of monocyte subsets in atherosclerosis.

Monocytes and macrophages play active roles in atherosclerosis, a chronic inflammatory disease that is a leading cause of death in the developed world. The prevailing paradigm states that, during human atherogenesis, monocytes accumulate in the arterial intima and differentiate into macrophages, which then ingest oxidized lipoproteins, secrete a diverse array of proinflammatory mediators, and eventually become foam cells, the key constituents of a vulnerable plaque. Yet monocytes are heterogeneous. In the mouse, one subset (Ly-6C(hi)) promotes inflammation, expands in hypercholesterolemic conditions, and selectively gives rise to macrophages in atheromata. A different subset (Ly-6C(lo)) attenuates inflammation and promotes angiogenesis and granulation tissue formation in models of tissue injury, but its role in atherosclerosis is largely unknown. In the human, monocyte heterogeneity is preserved but it is still unresolved how subsets correspond functionally. The contradistinctive properties of these cells suggest commitment for specific function before infiltrating tissue. Such commitment argues for discriminate targeting of deleterious subsets while sparing host defense and repair mechanisms. In addition to advancing our understanding of atherosclerosis, the ability to target and image monocyte subsets would allow us to evaluate drugs designed to selectively inhibit monocyte subset recruitment or function, and to stratify patients at risk for developing complications such as myocardial infarction or stroke. In this review we summarize recent advances of our understanding of the behavioral heterogeneity of monocytes during disease progression and outline emerging molecular imaging approaches to address key questions in the field.

[1]  Ralph Weissleder,et al.  Behavior of endogenous tumor-associated macrophages assessed in vivo using a functionalized nanoparticle. , 2009, Neoplasia.

[2]  Ralph Weissleder,et al.  Real-time assessment of inflammation and treatment response in a mouse model of allergic airway inflammation. , 2008, The Journal of clinical investigation.

[3]  Vasilis Ntziachristos,et al.  Real-Time Catheter Molecular Sensing of Inflammation in Proteolytically Active Atherosclerosis , 2008, Circulation.

[4]  P. Libby,et al.  The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models , 2008, Nature Reviews Immunology.

[5]  F. Geissmann,et al.  Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T‐cell responses , 2008, Immunology and cell biology.

[6]  M. Kikuyama,et al.  Adsorptive Depletion of Elevated Proinflammatory CD14+CD16+DR++ Monocytes in Patients With Inflammatory Bowel Disease , 2008, The American Journal of Gastroenterology.

[7]  R. Weissleder,et al.  Imaging in the era of molecular oncology , 2008, Nature.

[8]  S. Lira,et al.  Fractalkine Deficiency Markedly Reduces Macrophage Accumulation and Atherosclerotic Lesion Formation in CCR2−/− Mice: Evidence for Independent Chemokine Functions in Atherogenesis , 2008, Circulation.

[9]  Stephen W. Waldo,et al.  Heterogeneity of human macrophages in culture and in atherosclerotic plaques. , 2008, The American journal of pathology.

[10]  T. Simon,et al.  Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6Chi and Ly6Clo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice , 2008, Circulation.

[11]  F. Marincola,et al.  Tumour immunity: effector response to tumour and role of the microenvironment , 2008, The Lancet.

[12]  Zahi A. Fayad,et al.  Imaging of atherosclerotic cardiovascular disease , 2008, Nature.

[13]  Daniel J. Rader,et al.  Translating molecular discoveries into new therapies for atherosclerosis , 2008, Nature.

[14]  M. Pittet,et al.  Regulation of T‐cell migration and effector functions: insights from in vivo imaging studies , 2008, Immunological reviews.

[15]  P. Bousso,et al.  Decoding the dynamics of T cell–dendritic cell interactions in vivo , 2008, Immunological reviews.

[16]  P. Libby,et al.  Noninvasive In Vivo Imaging of Monocyte Trafficking to Atherosclerotic Lesions , 2008, Circulation.

[17]  Ralph Weissleder,et al.  Nanoparticle PET-CT Imaging of Macrophages in Inflammatory Atherosclerosis , 2008, Circulation.

[18]  Timur Shtatland,et al.  Osteogenesis Associates With Inflammation in Early-Stage Atherosclerosis Evaluated by Molecular Imaging In Vivo , 2007, Circulation.

[19]  A. Mildner,et al.  Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions , 2007, Nature Neuroscience.

[20]  L. Ziegler‐Heitbrock,et al.  Elevated CD16 expression by monocytes from patients with tumor necrosis factor receptor-associated periodic syndrome. , 2007, Arthritis and rheumatism.

[21]  P. Libby,et al.  The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions , 2007, The Journal of experimental medicine.

[22]  S. Gordon The macrophage: Past, present and future , 2007, European journal of immunology.

[23]  Elena Galkina,et al.  Vascular adhesion molecules in atherosclerosis. , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[24]  R. Weissleder,et al.  A Near-Infrared Cell Tracker Reagent for Multiscopic In Vivo Imaging and Quantification of Leukocyte Immune Responses , 2007, PloS one.

[25]  Steffen Jung,et al.  Lung Macrophages Serve as Obligatory Intermediate between Blood Monocytes and Alveolar Macrophages1 , 2007, The Journal of Immunology.

[26]  V. Fuster,et al.  (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. , 2007, Journal of the American College of Cardiology.

[27]  A. Cumano,et al.  Monitoring of Blood Vessels and Tissues by a Population of Monocytes with Patrolling Behavior , 2007, Science.

[28]  R. Weissleder,et al.  In vivo imaging of T cell delivery to tumors after adoptive transfer therapy , 2007, Proceedings of the National Academy of Sciences.

[29]  Sandy Schwemberger,et al.  THERMAL INJURY ELEVATES THE INFLAMMATORY MONOCYTE SUBPOPULATION IN MULTIPLE COMPARTMENTS , 2007, Shock.

[30]  N. Van Rooijen,et al.  Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis , 2007, The Journal of experimental medicine.

[31]  Zahi A Fayad,et al.  Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography , 2007, Nature Medicine.

[32]  Ralph Weissleder,et al.  Optical Visualization of Cathepsin K Activity in Atherosclerosis With a Novel, Protease-Activatable Fluorescence Sensor , 2007, Circulation.

[33]  Ralph Weissleder,et al.  Dual Channel Optical Tomographic Imaging of Leukocyte Recruitment and Protease Activity in the Healing Myocardial Infarct , 2007, Circulation research.

[34]  Christoph Peters,et al.  Cathepsin L Deficiency Reduces Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Knockout Mice , 2007, Circulation.

[35]  M. Mack,et al.  Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. , 2007, The Journal of clinical investigation.

[36]  Jean-Claude Tardif,et al.  Effect of torcetrapib on the progression of coronary atherosclerosis. , 2007, The New England journal of medicine.

[37]  L. Ziegler‐Heitbrock,et al.  The CD14+ CD16+ blood monocytes: their role in infection and inflammation , 2007, Journal of leukocyte biology.

[38]  Steffen Jung,et al.  Distinct Differentiation Potential of Blood Monocyte Subsets in the Lung1 , 2007, The Journal of Immunology.

[39]  Steffen Jung,et al.  Monocytes give rise to mucosal, but not splenic, conventional dendritic cells , 2007, The Journal of experimental medicine.

[40]  Zahi A Fayad,et al.  Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI , 2007, Proceedings of the National Academy of Sciences.

[41]  F. Tacke,et al.  Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. , 2007, The Journal of clinical investigation.

[42]  P. Libby,et al.  Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. , 2007, The Journal of clinical investigation.

[43]  A. Tall,et al.  The failure of torcetrapib: was it the molecule or the mechanism? , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[44]  J. Cello,et al.  Mac-1+ Cells Are the Predominant Subset in the Early Hepatic Lesions of Mice Infected with Francisella tularensis , 2006, Infection and Immunity.

[45]  F. Tacke,et al.  Migratory fate and differentiation of blood monocyte subsets. , 2006, Immunobiology.

[46]  Ralph Weissleder,et al.  A macrophage-targeted theranostic nanoparticle for biomedical applications. , 2006, Small.

[47]  P. Libby,et al.  Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease , 2006, Proceedings of the National Academy of Sciences.

[48]  Ralph Weissleder,et al.  Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. , 2006, Immunity.

[49]  Peter Libby,et al.  The immune response in atherosclerosis: a double-edged sword , 2006, Nature Reviews Immunology.

[50]  J. Gillard,et al.  Identifying Inflamed Carotid Plaques Using In Vivo USPIO-Enhanced MR Imaging to Label Plaque Macrophages , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[51]  Michael L. Dustin,et al.  Dynamic imaging of the immune system: progress, pitfalls and promise , 2006, Nature Reviews Immunology.

[52]  R. Tsien,et al.  The Fluorescent Toolbox for Assessing Protein Location and Function , 2006, Science.

[53]  F. Ginhoux,et al.  Immature monocytes acquire antigens from other cells in the bone marrow and present them to T cells after maturing in the periphery , 2006, The Journal of experimental medicine.

[54]  E. Pamer,et al.  Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2 , 2006, Nature Immunology.

[55]  R. Weissleder,et al.  Labeling of immune cells for in vivo imaging using magnetofluorescent nanoparticles , 2006, Nature Protocols.

[56]  S. Gordon,et al.  Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.

[57]  M. Creager,et al.  Atherosclerosis 2005: recent discoveries and novel hypotheses. , 2005, Circulation.

[58]  P. Sharp,et al.  Differentiation to the CCR2+ Inflammatory Phenotype In Vivo Is a Constitutive, Time-Limited Property of Blood Monocytes and Is Independent of Local Inflammatory Mediators1 , 2005, The Journal of Immunology.

[59]  R. Weissleder,et al.  Cell-specific targeting of nanoparticles by multivalent attachment of small molecules , 2005, Nature Biotechnology.

[60]  Vasilis Ntziachristos,et al.  Use of gene expression profiling to direct in vivo molecular imaging of lung cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[61]  A. Sica,et al.  Macrophage polarization comes of age. , 2005, Immunity.

[62]  F. Mach,et al.  Differential Influence of Chemokine Receptors CCR2 and CXCR3 in Development of Atherosclerosis In Vivo , 2005, Circulation.

[63]  L. Sibley,et al.  Recruitment of Gr-1+ monocytes is essential for control of acute toxoplasmosis , 2005, The Journal of experimental medicine.

[64]  V. de Waard,et al.  Repopulation of Apolipoprotein E Knockout Mice With CCR2-Deficient Bone Marrow Progenitor Cells Does Not Inhibit Ongoing Atherosclerotic Lesion Development , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[65]  Vasilis Ntziachristos,et al.  Looking and listening to light: the evolution of whole-body photonic imaging , 2005, Nature Biotechnology.

[66]  Ralph Weissleder,et al.  Detection of Vascular Adhesion Molecule-1 Expression Using a Novel Multimodal Nanoparticle , 2005, Circulation research.

[67]  S. Forbes,et al.  Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. , 2005, The Journal of clinical investigation.

[68]  Zahi A. Fayad,et al.  Molecular, cellular and functional imaging of atherothrombosis , 2004, Nature Reviews Drug Discovery.

[69]  Philippe Bousso,et al.  Dynamic behavior of T cells and thymocytes in lymphoid organs as revealed by two-photon microscopy. , 2004, Immunity.

[70]  Ralph Weissleder,et al.  Detection of Invasive Colon Cancer Using a Novel, Targeted, Library-Derived Fluorescent Peptide , 2004, Cancer Research.

[71]  E. Fisher,et al.  Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[72]  S. Blankenberg,et al.  CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-α levels , 2004, Thrombosis and Haemostasis.

[73]  N. Van Rooijen,et al.  Subpopulations of Mouse Blood Monocytes Differ in Maturation Stage and Inflammatory Response1 , 2004, The Journal of Immunology.

[74]  N. Van Rooijen,et al.  The Ly-6Chigh Monocyte Subpopulation Transports Listeria monocytogenes into the Brain during Systemic Infection of Mice1 , 2004, The Journal of Immunology.

[75]  G. Fingerle-Rowson,et al.  Expansion of CD14+CD16+Monocytes in Critically Ill Cardiac Surgery Patients , 1998, Inflammation.

[76]  S. Blankenberg,et al.  CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels. , 2004, Thrombosis and haemostasis.

[77]  Mariano G. Uberti,et al.  Tracking superparamagnetic iron oxide labeled monocytes in brain by high‐field magnetic resonance imaging , 2003, Journal of neuroscience research.

[78]  Steffen Jung,et al.  Blood monocytes consist of two principal subsets with distinct migratory properties. , 2003, Immunity.

[79]  Michel Sadelain,et al.  Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes , 2003, Nature Biotechnology.

[80]  Makoto Naito,et al.  Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. , 2003, The Journal of clinical investigation.

[81]  N. Maeda,et al.  Transplantation of Monocyte CC-Chemokine Receptor 2-Deficient Bone Marrow Into ApoE3-Leiden Mice Inhibits Atherogenesis , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[82]  P. Libby Inflammation in atherosclerosis , 2002, Nature.

[83]  J. Prinz,et al.  The CD14+CD16+ monocytes in erysipelas are expanded and show reduced cytokine production , 2002, European journal of immunology.

[84]  T. Espevik,et al.  The Proinflammatory CD14+CD16+DR++ Monocytes Are a Major Source of TNF1 , 2002, The Journal of Immunology.

[85]  G. Rothe,et al.  Enzymatically Degraded LDL Preferentially Binds to CD14high CD16+ Monocytes and Induces Foam Cell Formation Mediated Only in Part by the Class B Scavenger-Receptor CD36 , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[86]  E. Braunwald,et al.  Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris , 2001 .

[87]  M. Ernst,et al.  Heterogeneity of human peripheral blood monocyte subsets , 2001, Journal of leukocyte biology.

[88]  M. Scheinman Melvin Mayer Scheinman, MD: a conversation with the editor. , 2001, The American journal of cardiology.

[89]  D. Shih,et al.  Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice. , 2000, Circulation.

[90]  G. Schmitz,et al.  A more mature phenotype of blood mononuclear phagocytes is induced by fluvastatin treatment in hypercholesterolemic patients with coronary heart disease. , 1999, Atherosclerosis.

[91]  C. Weber,et al.  Distinct scavenger receptor expression and function in the human CD14+/CD16+monocyte subset. , 1999, American journal of physiology. Heart and circulatory physiology.

[92]  David K. Stevenson,et al.  Bioluminescent indicators in living mammals , 1998, Nature Medicine.

[93]  G. Schmitz,et al.  Peripheral blood mononuclear phagocyte subpopulations as cellular markers in hypercholesterolemia. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[94]  Melinda Fitzgerald,et al.  Immunol. Cell Biol. , 1995 .

[95]  A. B. Lyons,et al.  Determination of lymphocyte division by flow cytometry. , 1994, Journal of immunological methods.

[96]  F. Parhami,et al.  Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. , 1993, The Journal of clinical investigation.

[97]  D. Steinberg,et al.  Role of oxidised low density lipoprotein in atherogenesis. , 1993, British heart journal.

[98]  B. Passlick,et al.  Identification and characterization of a novel monocyte subpopulation in human peripheral blood. , 1989, Blood.

[99]  R. Ross,et al.  The pathogenesis of atherosclerosis (second of two parts). , 1976, The New England journal of medicine.

[100]  A. Siegelaub,et al.  The leukocyte count as a predictor of myocardial infarction. , 1974, The New England journal of medicine.

[101]  A. Volkman The origin and fate of the monocyte. , 1970, Series haematologica.

[102]  R. van Furth,et al.  THE ORIGIN AND KINETICS OF MONONUCLEAR PHAGOCYTES , 1968, The Journal of experimental medicine.

[103]  J. Gowans,et al.  THE ORIGIN OF MACROPHAGES FROM BONE MARROW IN THE RAT. , 1965, British journal of experimental pathology.